(IN BRIEF) Novonesis and Novo Nordisk have formed a research partnership to study how the gut microbiome can support metabolic health and help prevent obesity-related complications. The collaboration will explore synbiotic food supplements, combining probiotics and prebiotics, to assess their … Read the full press release
Posted in Business, Denmark, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged biomarkers, biosolutions, blood glucose, cardiometabolic health, cholesterol, gut microbiome, Henrik Joerck Nielsen, human health innovation, metabolic health, Nadeem Sarwar, Novo Nordisk, Novonesis, obesity prevention, partnership, prebiotics, probiotics, synbiotic supplements, Transformational Prevention Unit, World Health Organization
(IN BRIEF) Roche has announced new data at the Euretina Congress in Paris from its AVONELLE-X and SALWEEN studies of Vabysmo (faricimab), confirming the therapy’s strong long-term outcomes for patients with retinal diseases. The AVONELLE-X study, the largest long-term extension … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged AVONELLE-X, bispecific antibody, diabetic macular edema, DME, durability, Euretina Congress, extended dosing, faricimab, Levi Garraway, long-term efficacy, LUCERNE, nAMD, neovascular age-related macular degeneration, ophthalmology, PCV, polypoidal choroidal vasculopathy, retinal vein occlusion, Roche, RVO, SALWEEN, TENAYA, Vabysmo, vision loss
(IN BRIEF) Boehringer Ingelheim’s HERNEXEOS® (zongertinib tablets) has received accelerated approval in China for patients with advanced NSCLC carrying HER2 mutations who have progressed after prior therapy. The approval is supported by Beamion-LUNG 1 data, which showed a 71% objective … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged AACR 2025, Beamion-LUNG 1, Beamion-LUNG 2, Boehringer Ingelheim, breakthrough therapy designation, CHINA, HER2 mutations, HERNEXEOS, New England Journal of Medicine, NMPA approval, non-small cell lung cancer, NSCLC, oncology, partnership, Shashank Deshpande, targeted therapy, tyrosine kinase inhibitor, Wu Yilong, zongertinib
(IN BRIEF) Scientists at the Institute of Cancer Research, London, together with colleagues from TUD Dresden University of Technology, have discovered that oxidation of a single site in the protein p21 acts as a chemical switch determining whether cells keep … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged ageing, BIOTEC, cancer therapy, CDK2, cell cycle, cysteine 41, Institute of Cancer Research, Jörg Mansfeld, Julia Vorhauser, Molecular Cell, oxidative modification, p21, partnership, radiotherapy resistance, Reactive oxygen species, redox proteomics, senescence, TUD Dresden University of Technology
(IN BRIEF) The Helsinki Proteomics Center, a joint effort between HiLIFE’s Institute of Biotechnology and the Faculty of Medicine at the University of Helsinki, is enhancing Finland’s proteomics research capacity with the installation of three Thermo Scientific Orbitrap Astral and … Read the full press release
Posted in Business, Education, Financial, Finland, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged biobanks, Biocenter Finland, Faculty of Medicine, Finland life sciences, Helsinki Proteomics Center, HiLIFE, Institute of Biotechnology, Markku Varjosalo, Orbitrap Astral, Orbitrap Astral Zoom, partnership, patient registries, personalized medicine, protein interactions, proteomics, Research Council of Finland, structural biology, Thermo Scientific, translational medicine, University of Helsinki, XL-MS
(IN BRIEF) SGS has strengthened its crop science testing services in Canada with automated DNA extraction and molecular diagnostics to combat soilborne diseases like clubroot and Aphanomyces, which can severely impact crop rotations and persist for decades. Automation has increased … Read the full press release
Posted in Agriculture, Business, Environment, Financial, Government, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged Annu Albert, Aphanomyces, automation, biosecurity, Canadian agriculture, canola, clubroot, Crop Science, DNA extraction, genomic tools, Molecular Diagnostics, partnership, PCR analysis, pulses, robotics, seed growers, Seed World Canada, SGS, soil testing, sustainability
(IN BRIEF) Researchers at the Karlsruhe Institute of Technology (KIT) have created a nanodroplet-based chip platform that combines drug synthesis, biological testing, and chemical analysis in a single workflow. Each droplet measures only 200 nanoliters and contains 300 cells, enabling … Read the full press release
Posted in Business, Education, Financial, Germany, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged Angewandte Chemie, biotechnology, cancer research, Carsten Hopf, CeMOS, colon cancer, direct-to-biology, drug discovery, HT-29, Karlsruhe Institute of Technology, KIT, Liana Bauer, MALDI-MSI, MEK inhibitors, miniaturized workflow, mirdametinib, nanodroplet array platform, Pavel Levkin, pharmaceuticals, skin cancer, TH Mannheim
(IN BRIEF) Merck and mantro GmbH have established EdiMembre, Inc., a Massachusetts-based Deep Tech spin-out dedicated to advancing the alternative protein sector through Merck’s edible membrane technology. Designed to enable scalable production of structured cultivated meat and plant-based products, the … Read the full press release
Posted in Business, Financial, Germany, Government, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged alternative proteins, cultivated meat, cultured meat scaffolds, Deep Tech spin-out, edible membrane technology, EdiMembre, food security, Laura Matz, Manfred Tropper, mantro GmbH, Massachusetts, Merck, partnership, plant-based protein, protein innovation, Ryan Sylvia, structured meat production, sustainability, Timothy Ryan Olsen, venture building
(IN BRIEF) Boehringer Ingelheim has entered into a global collaboration and licensing agreement with Palatin Technologies to develop melanocortin receptor agonists as a new treatment for retinal diseases, beginning with diabetic retinopathy and diabetic macular edema. The approach targets inflammation, … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged biopharmaceutical collaboration, Boehringer Ingelheim, Carl Spana, diabetic macular edema, diabetic retinopathy, eye health innovation, inflammation, licensing agreement, melanocortin receptor agonists, neurodegeneration, Palatin Technologies, parttnership, Remko Bakker, Retinal Disease Treatment, vascular dysfunction, Vision Preservation, €280 million milestone payments
(IN BRIEF) Novartis will present 19 abstracts at the 2025 European Society of Cardiology (ESC) Congress in Madrid, showcasing new findings across its cardiovascular portfolio. Key highlights include two VictORION studies on Leqvio’s impact on quality of life and its … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged abelacimab, atrial fibrillation, AZALEA-TIMI 71, cardiovascular disease, cardiovascular pipeline therapies, Chagas disease, Entresto, ESC Congress 2025, European Society of Cardiology, heart failure, inclisiran, Leqvio, lipoprotein apheresis, lipoprotein(a), Lp(a)FRONTIERS APHERESIS trial, Novartis, PARACHUTE-HF trial, pelacarsen, Sacubitril Valsartan, VictORION studies, xRNA platform
(IN BRIEF) Montagu and Astorg have welcomed LGT Capital Partners as a new minority shareholder in Nemera, a global leader in drug delivery devices. Montagu and Astorg will remain majority shareholders while partnering with LGT CP to drive Nemera’s next … Read the full press release
Posted in Business, Germany, Healthcare, Investment, News, Pharma & Biotech, United Kingdom
Tagged Andreas Hellmann, Astorg, auto-injectors, biotech solutions, drug delivery devices, Global Expansion, Héloïse Pujolle, inhalers, innovation in healthcare, LGT Capital Partners, manufacturing capacity, Montagu, Nemera, Nicolas Marien, pharmaceutical manufacturing, private equity healthcare investments, proprietary product portfolio
(IN BRIEF) Sandoz has signed a 10-year virtual PPA with Elawan Energy to develop 150 MW of new solar capacity in Valladolid, Spain, expected to meet almost 90% of electricity demand for its European operations. This partnership is a key … Read the full press release
Posted in Business, Energy, Gas & Oil, Environment, Financial, Government, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, News, Pharma & Biotech, Science, Spain, Switzerland, Technology
Tagged biosimilar medicines, carbon footprint reduction, Castilla y León, clean energy, Climate Action, decarbonization, Elawan Energy, Europe, European operations, generic medicines, Glenn Gerecke, partnership, pharmaceutical industry sustainability, PPA, renewable energy, Sandoz, SBTi, Science Based Targets initiative, solar energy, sustainability, Valladolid, virtual power purchase agreement
(IN BRIEF) Novartis has reported landmark Phase III results showing that ianalumab significantly reduced disease activity in patients with Sjögren’s disease, meeting primary endpoints in both the NEPTUNUS-1 and NEPTUNUS-2 trials. The treatment, which combines B-cell depletion and BAFF-R inhibition, … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged autoimmune disease, B cell depletion, BAFF-R inhibition, biopharmaceuticals, clinical trial results, ESSDAI, Fast Track Designation, ianalumab, immunology research, MorphoSys AG, NEPTUNUS-1, NEPTUNUS-2, Novartis, Shreeram Aradhye, Sjögren’s disease, systemic autoimmune disorder, targeted therapy, US FDA, VAY736
IN BRIEF) SCHOTT Pharma has introduced the SCHOTT TOPPAC® cartridge, the first ready-to-use polymer cartridge to meet ISO dimensions, offering exceptional dimensional precision and broad device compatibility for injection systems such as pens. Made from COC and designed for sensitive … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged Andreas Reisse, biologics delivery, COC, CPHI Frankfurt, cross-linked siliconization layer, cyclic olefin copolymer, drug containment solutions, drug stability, glass cartridge portfolio, injection devices, ISO-compliant cartridge, overfill geometry, patient-friendly administration, PDA Universe of Pre-Filled Syringes, pen systems, polymer cartridge, prefillable polymer syringes, ready-to-use cartridge, SCHOTT Pharma, SCHOTT TOPPAC cartridge, St. Gallen manufacturing
(IN BRIEF) WACKER and Gearbox Biosciences have launched a partnership to co-develop advanced, antibiotic-free pDNA manufacturing techniques aimed at improving scalability, efficiency, and cost-effectiveness. Leveraging WACKER’s GMP biologics know-how and Gearbox’s Pop-Out-Plasmid® technology, the project will focus on streamlining workflows … Read the full press release
Posted in Business, Chemicals, Estonia, Financial, Germany, Government, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged advanced therapies, antibiotic resistance, antibiotic-free manufacturing, biomanufacturing, collaboration, cost-effectiveness, efficiency, ESETEC®, GEA, Gearbox Biosciences, GMP biologics, microbial fermentation, Munich Biotechnology Center, partnership, pDNA, plasmid DNA, PLASMITEC®, Pop-Out-Plasmid®, San Diego, Scalability, WACKER
(IN BRIEF) A collaborative study by the University of Copenhagen and Stanford University has revealed that pharmaceuticals possess unique isotopic signatures—based on stable isotopes of carbon, hydrogen and oxygen—that correspond to their manufacturing conditions. By profiling these δ²H, δ¹³C and … Read the full press release
Posted in Business, Denmark, Education, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged cellulose, corn starch, counterfeit detection, Else Holmfred, excipients, ibuprofen, isotope-ratio mass spectrometry, isotopes, partnership, pharmaceutical counterfeiting, stable isotope analysis, Stanford University, Stefan Stürup, University of Copenhagen, δ²H, δ¹³C, δ¹⁸O
(IN BRIEF) Sanofi has finalized its takeover of Vigil Neuroscience for roughly $470 million, acquiring all outstanding shares at $8 each and issuing a $2-per-share CVR tied to VG-3927’s first commercial sale. This deal, following Sanofi’s June 2024 strategic investment, … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged acquisition, Alzheimer’s disease, contingent value right, CVR, neurodegenerative research, Neurology, partnership, Phase 2 clinical study, preclinical pipeline, Sanofi, strategic investment, TREM2 agonist, VG-3927, VGL101, Vigil Neuroscience
(IN BRIEF) Almirall and Absci have expanded their AI-based drug discovery collaboration by selecting a second dermatological target, following the initial success of AI-designed antibody leads against a difficult-to-drug protein. Their partnership, active since November 2023, leverages Absci’s Integrated Drug … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Spain, Technology
Tagged Absci, AI drug discovery, Almirall, antibody leads, biotech collaboration, chronic skin disease, clinical development, de-novo design, Dermatology, generative AI, Integrated Drug Creation, Karl Ziegelbauer, milestone payments, partnership, Sean McClain, second target, wet-lab validation
(IN BRIEF) Fresenius Kabi has licensed rights from Polpharma Biologics to commercialize the vedolizumab biosimilar candidate PB016 globally—except in the Middle East and North Africa—once approved. Vedolizumab treats Crohn’s disease and ulcerative colitis, and PB016 references Takeda’s Entyvio®. The transaction … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Poland, Science, Technology
Tagged #FutureFresenius, (Bio)Pharma portfolio, chronic inflammatory diseases, Crohn's disease, denosumab biosimilar, Dr. Sang-Jin Pak, EC Approval, Entyvio, FDA approval, Fresenius Kabi, global commercialization, Konstantin Matentzoglu, licensing agreement, partnership, PB016, Polpharma Biologics S.A., Ulcerative colitis, Ustekinumab Biosimilar, vedolizumab biosimilar
(IN BRIEF) BioLabs | TUM is a new biotech incubator in Munich, created through a partnership between TUM Venture Labs, BioLabs, and Eli Lilly. Opening in early 2026 within an 1,800 m² refurbished building, the hub will host 15–20 early‑stage companies, providing fully equipped labs, … Read the full press release
Posted in Business, Education, Financial, Germany, Government, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged academic innovation, BioLabs, BioLabs | TUM, biotechnology hub, Catalyze360, coworking labs, deep‑tech ecosystem, early‐stage start‑ups, Eli Lilly and Company, global networks, lab infrastructure, mentorship, Mission BioCapital, Munich, partnership, R&D collaboration, therapeutic discovery, TUM Venture Labs, Unternehmertum
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?